1. Home
  2. BBNX vs NXRT Comparison

BBNX vs NXRT Comparison

Compare BBNX & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • NXRT
  • Stock Information
  • Founded
  • BBNX 2015
  • NXRT 2014
  • Country
  • BBNX United States
  • NXRT United States
  • Employees
  • BBNX N/A
  • NXRT N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • NXRT Real Estate Investment Trusts
  • Sector
  • BBNX Health Care
  • NXRT Real Estate
  • Exchange
  • BBNX Nasdaq
  • NXRT Nasdaq
  • Market Cap
  • BBNX 740.7M
  • NXRT 849.7M
  • IPO Year
  • BBNX 2025
  • NXRT N/A
  • Fundamental
  • Price
  • BBNX $26.41
  • NXRT $33.85
  • Analyst Decision
  • BBNX Strong Buy
  • NXRT Hold
  • Analyst Count
  • BBNX 10
  • NXRT 5
  • Target Price
  • BBNX $24.40
  • NXRT $39.83
  • AVG Volume (30 Days)
  • BBNX 690.5K
  • NXRT 186.4K
  • Earning Date
  • BBNX 11-06-2025
  • NXRT 10-28-2025
  • Dividend Yield
  • BBNX N/A
  • NXRT 6.03%
  • EPS Growth
  • BBNX N/A
  • NXRT N/A
  • EPS
  • BBNX N/A
  • NXRT N/A
  • Revenue
  • BBNX $69,830,000.00
  • NXRT $254,446,000.00
  • Revenue This Year
  • BBNX $42.80
  • NXRT N/A
  • Revenue Next Year
  • BBNX $34.58
  • NXRT $4.22
  • P/E Ratio
  • BBNX N/A
  • NXRT N/A
  • Revenue Growth
  • BBNX 38911.17
  • NXRT N/A
  • 52 Week Low
  • BBNX $8.89
  • NXRT $29.98
  • 52 Week High
  • BBNX $26.66
  • NXRT $48.31
  • Technical
  • Relative Strength Index (RSI)
  • BBNX 85.28
  • NXRT 53.88
  • Support Level
  • BBNX $18.12
  • NXRT $33.20
  • Resistance Level
  • BBNX $19.32
  • NXRT $34.87
  • Average True Range (ATR)
  • BBNX 1.35
  • NXRT 0.65
  • MACD
  • BBNX 0.75
  • NXRT 0.07
  • Stochastic Oscillator
  • BBNX 97.43
  • NXRT 47.17

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

Share on Social Networks: